Key result
New RCT evaluates if HAL-assisted exercise improves rehabilitation versus conventional training in chronic heart failure.
Why the study?
The efficacy of exercise therapy assisted by a lumbar-type hybrid assistive limb (HAL) compared to conventional training in patients with chronic heart failure is unknown.
Does exercise therapy with assistance from a lumbar-type hybrid assistive limb improve rehabilitation outcomes and prognosis in patients with chronic heart failure?
RCT (n=60)
Open-label
1:1 allocation ratio
No
Does exercise therapy with assistance from a lumbar-type hybrid assistive limb improve rehabilitation outcomes and prognosis in patients with chronic heart failure?
This protocol describes a randomized controlled trial to evaluate the efficacy and feasibility of using a lumbar-type hybrid assistive limb during cardiac rehabilitation for patients with chronic heart failure.
The hybrid assistive limb (HAL) provides motion assistance based on bioelectrical signals detected on the skin surface when muscle forces are generated. The lumbar-type HAL is expected to expand the therapeutic options for severe cardiac patients who have difficulty in moving on their own legs. We aim to compare the efficacy of exercise therapy performed with assistance from a lumbar-type HAL versus conventional training (sit-to-stand exercise without HAL) in patients with chronic heart failure. This investigation will be a randomized, nonblinded, controlled study. Sixty patients who satisfy the criteria to receive cardiac rehabilitation therapy under the Japanese national insurance system will be enrolled at the University of Tsukuba Hospital. Participants randomly assigned to 2 groups (HAL group and conventional group) at a 1:1 allocation ratio will perform exercise therapy either with HAL or without HAL for 5-30 min once a day for 6-10 days. Outcome parameters will be measured just before and after the completion of the exercise therapy and at 1 year after hospital discharge. The primary outcomes will be the heart rate, blood pressure, subjective ratings of exercise intensity during exercise (Borg scale), number of days from the start of exercise therapy to independent walking and to discharge, and prognosis (mortality and cardiovascular events) over the 1-year period after discharge. The secondary outcomes will be the assessment of heart failure severity, brain natriuretic peptide, grip strength, thigh muscle thickness, isometric knee extensor strength, standing ability, 10-meter walking speed, 6-min walking distance, short physical performance battery, and adverse events. Unpaired t tests will be used for baseline assessments and outcome measures. This is the first randomized controlled study to examine the efficacy and feasibility of lumbar-type HAL in patients with chronic heart failure. If the results confirm beneficial effects in the outcomes of patients with heart failure, this study will add more evidence in support of the use of the lumbar-type HAL as an effective tool in new cardiac rehabilitation programs.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2019) conducted an RCT in chronic heart failure (n=60). Lumbar-type hybrid assistive limb (HAL) assisted exercise therapy vs. Conventional training (sit-to-stand exercise without HAL) was evaluated on Heart rate, blood pressure, subjective ratings of exercise intensity (Borg scale), days to independent walking and discharge, and prognosis (mortality and cardiovascular events) over 1 year. This protocol outlines a randomized controlled trial to evaluate whether lumbar-type HAL-assisted exercise therapy improves rehabilitation outcomes compared to conventional training in chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: